Get notified when RNAZ files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTranscode Therapeutics schedules 2026 annual meeting for July 2, sets proposal deadline
Filed June 1, 2026 · Period ending May 29, 2026 · ~1 min read
Key Changes
-
low
Annual stockholder meeting scheduled for July 2, 2026, with record date of May 28, 2026 for voting eligibility. Meeting date is more than 30 days earlier than the 2025 meeting held on August 29.
Item 8.01 view on EDGAR → -
low
Stockholders must submit proposals for proxy inclusion by June 11, 2026 at 5:00 p.m. ET. The accelerated deadline is ten days from this announcement due to the earlier meeting date.
Item 8.01 view on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.
Partner
Trade RNAZ commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify